Indeed, reduction of TGFβ signaling in the mammary gland has been associated with inappropriate differentiation and accelerated tumorigenesis in numerous models, and reduced expression of TGFβ receptors in breast cancer patients correlates with disease progression (reviewed in [5-7]). The gene discussed is TGFB1; the disease is breast cancer.